Kyunghee Burkitt, DO, PhD
- Specialty: Hematology and Oncology
-
Primary Location: 3909 Orange Pl (7 mi.)
Other Locations - Languages Spoken: English
Office Locations
UH Seidman Minoff Health Center (7 mi.)
3909 Orange Pl
Ste 1100
Beachwood, OH 44122
216-896-1750
UH Seidman Cancer Center (0 mi.)
11100 Euclid Ave
1st Floor
Cleveland, OH 44106
216-844-3951
Biography: Kyunghee Burkitt, DO, PhD
Titles
- Assistant Professor, CWRU School of Medicine
Certifications & Memberships
- Medical Oncology - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Education
Fellowship | Hematology/Oncology
Hematology/Oncology - National Cancer Institute (NCI) (2017 - 2020)
Residency | Internal Medicine
Internal Medicine - Sparrow Hospital (2014 - 2017)
Medical Education
Michigan State University College Of Osteopathic Medicine (2009 - 2014)
Other Education
Michigan State University (1995 - 2000)
Other Education
University Of Michigan (2007)
Undergraduate
Hoseo University (1995)
About
Kyunghee Burkitt, DO, PhD, is a medical oncologist at University Hospitals and is board certified in internal medicine.
Dr. Burkitt earned a BS in biochemistry from South Korea and a MS in cancer biology at Michigan State University in East Lansing, Mich. She went on to receive her PhD in cancer biology/toxicology at University of Michigan Cancer Center in Ann Arbor, Mich. After completing postdoctoral fellowships in hematology/oncology at University of Michigan and Michigan State University, she earned her medical degree at Michigan State University College of Osteopathic Medicine.
Dr. Burkitt completed her internal medicine residency training at Michigan State University, Sparrow Hospital in Lansing, Michigan, and a fellowship in medical oncology at the National Cancer Institute.
Dr. Burkitt is very active in research and has been published in numerous manuscripts. Research topics include epigenetic modification, DNA damage response pathways and introduction of novel therapies in clinical trials for head and neck cancer. Her clinical interests include improving response to chemotherapy and radiation therapy and immunotherapy in head and neck cancers.
Featured Videos
Watch to find out more about this University Hospitals provider.
Patient Experience Reviews
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Kyunghee Burkitt did not disclose any Outside Relationships with Industry.